Cook Medical Plans Rapid Scale-Up Of Newly Launched ENT Unit
This article was originally published in The Gray Sheet
Firm unveils a range of new products for minimally invasive treatment of ear, nose and throat conditions Sept. 10 at the American Academy of Otolaryngology-Head and Neck Surgery annual conference in Washington, D.C.
You may also be interested in...
FDA panel unanimously endorses Inspire upper airway stimulator. Stryker buys Berchtold and Pivot. First randomized U.S. study of embolic protection during transcatheter aortic valve replacement approved. More news.
Johnson & Johnson/Ethicon will use its $785 million acquisition of Acclarent, developer of the Balloon Sinuplasty system for chronic sinusitis, as a platform for growth in the ear, nose and throat business
FDA launches what it hopes will the final push to reform the regulatory oversight system for lab-developed tests by proposing a relatively rapid transition period to require essentially all LDTs to comply with the existing regulations for in vitro diagnostics. Legislation, litigation, and industry negotiation will likely shape the final product.